Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease¿EXVEDOCOL
Viviana Parra; Sandra Cifuentes; Sandra Avendaño; Enrique Ponce de León; Cristian Florez; Gustavo Reyes; Fabian Puentes; Manuel Ballesteros; Edilberto Nuñez; Federico Gómez; Juan Ricardo Márquez;
Gastroenterol Hepatol. 2024;47:858-66
De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice
Alex Arenas; María José Moreta; Ingrid Ordás; Agnès Fernández-Clotet; Berta Caballol; Marta Gallego; Alejandro Vara; Rebeca Barastegui; Angel Giner; Cristina Prieto; Maria Carme Masamunt; Roberto Candia; Elena Ricart;
Gastroenterol Hepatol. 2024;47:673-82
Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe inflammatory bowel disease in Argentina: Data from the RISE-AR study
Pablo Andres Olivera; Domingo Balderramo; Juan Sebastian Lasa; Ignacio Zubiaurre; Gustavo Correa; Pablo Lubrano; Orlando Ruffinengo; Martin Yantorno; Astrid Rausch; Gisela Piñero; Andrea Bolomo; Carla Amigo; Jazmin El-Hakeh; Daiana Beatriz Leonardi; Laura Brion; Alicia Sambuelli;
Gastroenterol Hepatol. 2025;48: